{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T05:38:28Z","timestamp":1772948308203,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-024-03397-4","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T04:02:00Z","timestamp":1727496120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus"],"prefix":"10.1186","volume":"26","author":[{"given":"Carlos","family":"Rafael-Vidal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mart\u00ednez-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Malvar-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Altab\u00e1s-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coral","family":"Mouri\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Pazos-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Fraga-Bau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Pego Reigosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"11","key":"3397_CR1","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1177\/2047487314546826","volume":"22","author":"F Ballocca","year":"2015","unstructured":"Ballocca F, D\u2019Ascenzo F, Moretti C, Omed\u00e8 P, Cerrato E, Barbero U, et al. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Eur J Prev Cardiol. 2015;22(11):1435\u201341.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"3397_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ijcard.2014.08.006","volume":"176","author":"CY Lin","year":"2014","unstructured":"Lin CY, Shih CC, Yeh CC, Chou WH, Chen TL, Liao CC. Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies. Int J Cardiol. 2014;176(3):847\u201351.","journal-title":"Int J Cardiol"},{"issue":"9","key":"3397_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515\u201332.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"3397_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41584-022-00770-y","volume":"18","author":"A Mak","year":"2022","unstructured":"Mak A, Chan JKY. Endothelial function and endothelial progenitor cells in systemic lupus erythematosus. Nat Rev Rheumatol. 2022;18(5):286\u2013300.","journal-title":"Nat Rev Rheumatol"},{"key":"3397_CR5","doi-asserted-by":"crossref","unstructured":"Ambler WG, Kaplan MJ. Vascular damage in systemic lupus erythematosus. Nat Rev Nephrol. 2024;20(4):251\u201365.","DOI":"10.1038\/s41581-023-00797-8"},{"issue":"23","key":"3397_CR6","doi-asserted-by":"publisher","first-page":"12874","DOI":"10.3390\/ijms222312874","volume":"22","author":"D Morrone","year":"2021","unstructured":"Morrone D, Picoi MEL, Felice F, De Martino A, Scatena C, Spontoni P, et al. Endothelial progenitor cells: An appraisal of relevant data from bench to bedside. Int J Mol Sci. 2021;22(23):12874.","journal-title":"Int J Mol Sci."},{"issue":"2","key":"3397_CR7","first-page":"93","volume":"9","author":"TFJ King","year":"2014","unstructured":"King TFJ, McDermott JH. Endothelial progenitor cells and cardiovascular disease. J Stem Cells. 2014;9(2):93\u2013106.","journal-title":"J Stem Cells"},{"issue":"10","key":"3397_CR8","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3390\/cells11101678","volume":"11","author":"PP Heinisch","year":"2022","unstructured":"Heinisch PP, Bello C, Emmert MY, Carrel T, Dre\u00dfen M, H\u00f6rer J, et al. Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review. Cells. 2022;11(10):1678.","journal-title":"Cells."},{"issue":"9\u201310","key":"3397_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2119\/molmed.2011.00129","volume":"17","author":"RJ Medina","year":"2011","unstructured":"Medina RJ, O\u2019Neill CL, O\u2019Doherty TM, Knott H, Guduric-Fuchs J, Gardiner TA, et al. Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Mol Med. 2011;17(9\u201310):1045\u201355.","journal-title":"Mol Med"},{"key":"3397_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.682367","volume":"8","author":"H Zhao","year":"2021","unstructured":"Zhao H, He Y. The Inhibitory Effect of Lysophosphatidylcholine on Proangiogenesis of Human CD34(+) Cells Derived Endothelial Progenitor Cells. Front Mol Biosci. 2021;8: 682367.","journal-title":"Front Mol Biosci"},{"issue":"8","key":"3397_CR11","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","volume":"110","author":"MF Denny","year":"2007","unstructured":"Denny MF, Thacker S, Mehta H, Somers EC, Dodick T, Barrat FJ, et al. Interferon-\u03b1 promotes abnormal vasculogenesis in lupus: A potential pathway for premature atherosclerosis. Blood. 2007;110(8):2907\u201315.","journal-title":"Blood"},{"issue":"4","key":"3397_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2283","volume":"9","author":"JRAJ Moonen","year":"2007","unstructured":"Moonen JRAJ, de Leeuw K, van Seijen XJGY, Kallenberg CGM, van Luyn MJA, Bijl M, et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther. 2007;9(4):1\u201310.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"3397_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/ard.2006.065631","volume":"66","author":"PE Westerweel","year":"2007","unstructured":"Westerweel PE, Luijten RKMAC, Hoefer IE, Koomans HA, Derksen RHWM, Verhaar MC. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus. Ann Rheum Dis. 2007;66(7):865\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3397_CR14","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00296-009-1156-4","volume":"30","author":"XL Deng","year":"2010","unstructured":"Deng XL, Li XX, Liu XY, Sun L, Liu R. Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage. Rheumatol Int. 2010;30(11):1429\u201336.","journal-title":"Rheumatol Int"},{"issue":"10","key":"3397_CR15","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/rheumatology\/ken286","volume":"47","author":"J Grisar","year":"2008","unstructured":"Grisar J, Steiner CW, Bonelli M, Karonitsch T, Schwarzinger I, Weigel G, et al. Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology. 2008;47(10):1476\u201383.","journal-title":"Rheumatology"},{"issue":"6","key":"3397_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00296-010-1377-6","volume":"31","author":"JN Ablin","year":"2011","unstructured":"Ablin JN, Boguslavski V, Aloush V, Elkayam O, Paran D, Levartovski D, et al. Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE. Rheumatol Int. 2011;31(6):773\u20138.","journal-title":"Rheumatol Int"},{"issue":"4","key":"3397_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/0961203308097572","volume":"18","author":"E Robak","year":"2009","unstructured":"Robak E, Kierstan M, Cebula B, Krawczynska A, Sysa-Jedrzejowska A, Wierzbowska A, et al. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus. Lupus. 2009;18(4):332\u201341.","journal-title":"Lupus"},{"issue":"10","key":"3397_CR18","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1093\/rheumatology\/kes152","volume":"51","author":"J Rodr\u00edguez-Carrio","year":"2012","unstructured":"Rodr\u00edguez-Carrio J, Prado C, De Paz B, L\u00f3pez P, G\u00f3mez J, Alperi-L\u00f3pez M, et al. Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients. Rheumatology (United Kingdom). 2012;51(10):1775\u201384.","journal-title":"Rheumatology (United Kingdom)."},{"issue":"9","key":"3397_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3397_CR20","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis and Rheumatology. 2019;71(9):1400\u201312.","journal-title":"Arthritis and Rheumatology"},{"issue":"10","key":"3397_CR21","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/art.40925","volume":"71","author":"C Sobchak","year":"2019","unstructured":"Sobchak C, Akhtari S, Harvey P, Gladman D, Chandran V, Cook R, et al. Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients With Psoriatic Disease. Arthritis and Rheumatology. 2019;71(10):1651\u20139.","journal-title":"Arthritis and Rheumatology"},{"issue":"9","key":"3397_CR22","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","volume":"75","author":"K Franklyn","year":"2016","unstructured":"Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, et al. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis. 2016;75(9):1615\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3397_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/lupus-2021-000538","volume":"8","author":"RF van Vollenhoven","year":"2021","unstructured":"van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, et al. 2021 DORIS definition of remission in SLE: Final recommendations from an international task force. Lupus Sci Med. 2021;8(1):1\u20139.","journal-title":"Lupus Sci Med"},{"issue":"3","key":"3397_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996Mar;39(3):363\u20139.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3397_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/annrheumdis-2018-214502","volume":"78","author":"D Jesus","year":"2019","unstructured":"Jesus D, Matos A, Henriques C, Zen M, Larosa M, Iaccarino L, et al. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity. Ann Rheum Dis. 2019;78(3):365\u201371.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3397_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/annrheumdis-2012-202753","volume":"72","author":"J L\u00fcbbers","year":"2013","unstructured":"L\u00fcbbers J, Brink M, van de Stadt LA, Vosslamber S, Wesseling JG, van Schaardenburg D, et al. The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Ann Rheum Dis. 2013;72(5):776\u201380.","journal-title":"Ann Rheum Dis"},{"key":"3397_CR27","doi-asserted-by":"crossref","unstructured":"Rafael-Vidal C, Mart\u00ednez-Ramos S, Malvar-Fern\u00e1ndez B, Altab\u00e1s-Gonz\u00e1lez I, Mouri\u00f1o C, Veale DJ, et al. Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner. Front Immunol. 2023 Dec 14;14(December):1061.1\u20131061. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1277267\/full.","DOI":"10.1136\/annrheumdis-2023-eular.2564"},{"issue":"6","key":"3397_CR28","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1160\/TH05-07-0499","volume":"94","author":"B Delorme","year":"2005","unstructured":"Delorme B, Basire A, Gentile C, Sabatier F, Monsonis F, Desouches C, et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within CD146+ blood cells. Thromb Haemost. 2005;94(6):1270\u20139.","journal-title":"Thromb Haemost"},{"issue":"112","key":"3397_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102486","volume":"2020","author":"K Komici","year":"2020","unstructured":"Komici K, Faris P, Negri S, Rosti V, Garc\u00eda-Carrasco M, Mendoza-Pinto C, et al. Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca2+ signaling: A novel approach for an old disease. J Autoimmun. May2020;2020(112): 102486.","journal-title":"J Autoimmun"},{"issue":"11","key":"3397_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ncprheum0647","volume":"3","author":"Z Szekanecz","year":"2007","unstructured":"Szekanecz Z, Koch AE. Mechanisms of Disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol. 2007;3(11):635\u201343.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"9","key":"3397_CR31","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/kez528","volume":"59","author":"I Parodis","year":"2020","unstructured":"Parodis I, Gokaraju S, Zickert A, Vanarsa K, Zhang T, Habazi D, et al. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. Rheumatology (Oxford). 2020Sep;59(9):2237\u201349.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"3397_CR32","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/cvr\/cvz132","volume":"115","author":"G Caligiuri","year":"2019","unstructured":"Caligiuri G. Mechanotransduction, immunoregulation, and metabolic functions of CD31 in cardiovascular pathophysiology. Cardiovasc Res. 2019;115(9):1425\u201334.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"3397_CR33","doi-asserted-by":"publisher","first-page":"e37000","DOI":"10.1371\/journal.pone.0037000","volume":"7","author":"EC Somers","year":"2012","unstructured":"Somers EC, Zhao W, Lewis EE, Wang L, Wing JJ, Sundaram B, et al. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients. PLoS One. 2012;7(5):e37000.","journal-title":"PLoS One."},{"key":"3397_CR34","doi-asserted-by":"publisher","unstructured":"Wu GC, Liu HR, Leng RX, Li XP, Li XM, Pan HF, et al. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis. Autoimmun Rev. 2016;15(1):22\u201337. Available from: https:\/\/doi.org\/10.1016\/j.autrev.2015.10.002.","DOI":"10.1016\/j.autrev.2015.10.002"},{"key":"3397_CR35","doi-asserted-by":"publisher","unstructured":"Privratsky JR, Tilkens SB, Newman DK, Newman PJ. PECAM-1 dampens cytokine levels during LPS-induced endotoxemia by regulating leukocyte trafficking. Life Sci. 2012;90(5\u20136):177\u201384. Available from: https:\/\/doi.org\/10.1016\/j.lfs.2011.11.002.","DOI":"10.1016\/j.lfs.2011.11.002"},{"issue":"8","key":"3397_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.4049\/jimmunol.2300468","volume":"211","author":"Y Rui","year":"2023","unstructured":"Rui Y, Liu X, Li N, Jiang Y, Chen G, Cao X, et al. Expression of Concern: PECAM-1 Ligation Negatively Regulates TLR4 Signaling in Macrophages. J Immunol. 2023;211(8):1251\u20131251.","journal-title":"J Immunol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03397-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03397-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03397-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T04:07:27Z","timestamp":1727496447000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03397-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3397"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03397-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics Committee of Galicia (study number 2020\/158) approved this study and all patients supplied written informed consent to be included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}